[1]
E. A. Mellon, “Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma”, AO, vol. 54, no. 7, pp. 979–985, Aug. 2015.